Kangstem Biotech Obtains Domestic Patent for Large-Scale Cultivation Technology of Adult Stem Cells
[Asia Economy Reporter Minji Lee] Kangstem Biotech announced on the 26th that it has obtained a domestic patent for its technology to develop high-performance adult stem cells, promoting proliferation, multipotency, and reprogramming.
This patent establishes standardized culture conditions through spherical growth that maintain an undifferentiated state, enabling the production of adult stem cells with CD49f-positive characteristics that promote stem cell proliferation, multipotency, and reprogramming without undergoing costly steps in the process.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The company stated, "Based on this, we will be able to manufacture highly efficient stem cell therapeutics," adding, "It can also be used for the treatment of immune-related diseases as well as neurological, cardiovascular, and skeletal system disorders."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
